1. Roche's risdiplam deal a relief for SMA rivals Biogen and Novartis--for now— AstraZeneca targets summer start for COVID-19 antibody trial — Keros Therapeutics raises $96M in upsized IPO — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

AdComm

Discussion in 'Insmed' started by anonymous, Aug 7, 2018 at 1:20 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Anyone following? FDA questioning correlation between sputum culture conversion and lack of clinical benefit.
     

  2. anonymous

    anonymous Guest

    This is tough Anyone happy